Bikang shares: invest 500 million yuan to establish a subsidiary to participate in the production of lithium carbonate and lithium batteries

<

  On October 23, Jiangsu Bikang Pharmaceutical Co., Ltd. (hereinafter referred to as “Company” or “Bikang Shares”) announced that the company intends to use its own funds to invest RMB 500 million to set up Jiangsu North Duxin in Xinyi City, Jiangsu Province. Energy Co., Ltd. (hereinafter referred to as "the target company"), expanding the industrial chain of new energy fields. The company subscribes to the registered capital of the company and holds 100% of its equity.

Bikang said that the company, in combination with its own competitive advantages in the field of new energy, actively responded to the policy orientation of the state's advocacy for the development of new energy industries, implemented the dual-main business development strategy of medical health and new energy and new materials, and seized market opportunities. Deepen the field of new energy, consolidate the company's position in the new energy industry, and enhance the company's sustainable profitability and comprehensive competitiveness.

The company's business scope: lithium carbonate, butyl lithium, chlorobutane, cyclohexane, lithium metal, lithium hydroxide, lithium fluoride, lithium hydride, lithium oxide, lithium aluminum hydride, lithium silicon alloy, lithium aluminum alloy, sulfuric acid , hydrochloric acid, lithium ion battery, lithium ion battery material, charging station, charging post, charger, electronic products (excluding radio transmission terminal equipment), lithium ion battery electric vehicle (including electric bicycle, electric motorcycle, non-road traffic electric Research, development, production, sales and related technical services of the car; self-operated and agent import and export of various commodities and technologies.

It is understood that Shaanxi Bikang is one of the industrial enterprises with the full dosage form and the largest number of varieties in the domestic pharmaceutical industry. At present, the company's products can be divided into pharmaceutical sectors, new energy and new materials, and pharmaceutical intermediates. (Pharmaceutical intermediates, pesticide intermediates) Three major categories of plates.

The company's new energy product, lithium hexafluorophosphate, is the solute of lithium battery electrolyte. The current production capacity is 5,000 tons/year. Affected by the policy adjustment of the new energy auto industry at the beginning of the year, the company's downstream customers' orders for new energy products decreased during the reporting period, and operating income and operating profit decreased slightly compared with the same period of last year. In the second half of the year, the company will seize the opportunity of the recovery of new energy products market, gradually release production capacity and enhance the company's profitability. The new material products produced by the company are high-strength and high-modulus polyethylene fiber. The existing production capacity is 3,200 tons/year. During the reporting period, the company's new high-strength high-modulus polyethylene fiber expansion project with an annual output of 6,800 tons has started construction, and will be gradually put into production and release production capacity. .

According to public information, in the first half of the year, the company achieved operating income of 1.731 billion yuan, down 5.83% year-on-year; net profit was 456 million yuan, down 5.9145% year-on-year; earnings per share was 0.30 yuan. In the first three quarters of the company, the company achieved operating income of 3.292 billion yuan, a year-on-year increase of 23.75%; net profit was 621 million yuan, down 9.9525%; earnings per share was 0.41 yuan.

Hydraulic Pilot Operated Check Valve

Hydraulic Pilot Operated Check Valve

Jiangsu haohong hydraulic Co.Ltd , https://www.jshhhydraulic.com